All of Us study identifies thousands of new pharmacogenomic variants in diverse US population
Analysis of nearly 100,000 participants in the NIH All of Us programme has uncovered thousands of previously undescribed variants in genes governing drug response, with gains concentrated in populations historically underrepresented in genomic research.